KBLB Stock — Kraig Biocraft Labs

Kraig Biocraft Labs (KBLB)

Updated October 16, 2026.

KBLB is a Stock. Total return is 71.0% over the past 18.6 years, 631.8 points behind SPY at 702.8%.

Kraig Biocraft Laboratories develops and commercializes recombinant spider silk fibers produced in genetically engineered silkworms, with applications across performance apparel, workwear, medical devices, ballistic protection, and specialty industrial uses. The company does not currently have an established distribution schedule. This early-stage biotechnology company appeals primarily to investors interested in specialized materials innovation and long-term growth potential rather than current income generation.

KBLB performance versus SPY

Price and return data through 2026-10-16.

Total return is 71.0% over the past 18.6 years, 631.8 points behind SPY at 702.8%. Over the past year its total return — price change plus distributions reinvested — is -5.0%. Its deepest 1-year drawdown was 56.2%.

KBLB key facts

Asset type

Stock

Asset class

Equity

Inception date

02/29/2008

Distribution frequency

None

Last close

$0.09 (as of 2026-10-16)

Market cap

$95,361,063

Average volume

232810.0

Beta

1.584

Payout ratio

0.0%

EPS

$0.00

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

KBLB risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 56.2%.

Who may consider KBLB — and who may not

It is a weaker fit for investors who need monthly cash flow (KBLB does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on KBLB

• All tickers starting with K

Tagged: Materials.

Frequently asked questions